Aerpio Pharmaceuticals to Present Data Demonstrating Role of VE-PTP in Conventional Outflow Homeostasis and the Potential of AKB-9778\, a VE-PTP Inhibitor/Tie2 Activator\, as a Treatment for Open-Angle Glaucoma